Pricing and Reimbursement

A significant advancement in cancer treatment was marked today as Immunocore secured reimbursement approval from England's National Health Service (NHS) for KIMMTRAK, offering a...

AstraZeneca GmbH has expanded the use of Durvalumab (IMFINZI) for adults battling advanced or recurrent endometrial carcinoma. This new treatment regimen pairs Durvalumab with...

The Joint Federal Committee (G-BA) announced the removal of six specific medical products from Germany’s reimbursable list, effective immediately after their announcement in the...

Sanofi-Aventis Deutschland GmbH has initiated a benefit assessment process for Dupilumab, marketed as Dupixent, targeting a new therapeutic application for eosinophilic esophagitis in children...

In a significant decision on November 25, 2024, the Transparency Council sanctioned the inclusion of pomalidomide in the reimbursement list for treating plasmocytic myeloma....

Key aspectsEvaluation under chapter 5, paragraph 1, subparagraph 2 of the VerfO; Further assessment under section 35a paragraph 1 sentence 12 SGB V,...

Key TakeawaysCarvykti must provide detailed comparative studies against standard therapies. • The suspension underscores the importance of value-based assessments for high-revenue orphan drugs. • Pharmaceutical...

Key TakeawaysAUGTYRO’s inclusion could lead to enhanced survival rates for ROS1-positive NSCLC patients in China. Renewal of NUZYRA may result in better management...

Key TakeawaysViatris' commitment is crucial for long-term supply stability. Transitioning brands may require patient education and support. Funding alternative treatments like oestradiol gel...

key TakeawaysIncreased biosimilar options may foster competitive pricing in the pharmaceutical market. Clearer guidelines could expedite the approval and integration of future biosimilars. ...

Key TakeawaysFacilitates centralized reporting, reducing administrative burdens on MAHs Enhances real-time data availability for quicker response to shortages Improves coordination between EMA, national...

The Gemeinsame Bundesausschuss (G-BA) has formally approved significant revisions to the ATMP Quality Assurance Guideline, ensuring compatibility with the updated ICD-10-GM and OPS coding...

Key Takeaways • Streamlined process for healthcare providers • No action required for existing approvals • Improved patient experience through tailored forms Patients seeking stimulant medications for ADHD...

Key TakeawaysAztreonam/Avibactam addresses critical bacterial infections with limited treatment options. Economic evaluation will influence reimbursement decisions and patient accessibility. Data accuracy from pharmaceutical...

Key TakeawaysPhonocardiography's approval depends on its proven efficacy in diagnosing CHD. Healthcare providers may need to revise diagnostic protocols based on the committee's...